HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Monoclonal antibodies capable of binding SARS-CoV-2 spike protein receptor-binding motif specifically prevent GM-CSF induction.

Abstract
A severe acute respiratory syndrome (SARS)-like coronavirus 2 (SARS-CoV-2) has recently caused a pandemic COVID-19 disease that infected approximately 94 million and killed more than 2,000,000 people worldwide. Like the SARS-CoV, SARS-CoV-2 also employs a receptor-binding motif (RBM) of its envelope spike protein for binding the host angiotensin-converting enzyme 2 (ACE2) to gain viral entry. Currently, extensive efforts are being made to produce vaccines against a surface fragment of a SARS-CoV-2, such as the spike protein, in order to boost protective antibodies that can inhibit virus-ACE2 interaction to prevent viral entry. It was previously unknown how spike protein-targeting antibodies would affect innate inflammatory responses to SARS-CoV-2 infections. Here we generated a highly purified recombinant protein corresponding to the RBM of SARS-CoV-2, and used it to screen for cross-reactive monoclonal antibodies (mAbs). We found two RBM-binding mAbs that competitively inhibited its interaction with human ACE2, and specifically blocked the RBM-induced GM-CSF secretion in both human peripheral blood mononuclear cells and murine macrophage cultures. Our findings have suggested a possible strategy to prevent SARS-CoV-2-elicited "cytokine storm," and revealed a potentially anti-inflammatory and protective mechanism for SARS-CoV-2 spike-based vaccines.
AuthorsXiaoling Qiang, Shu Zhu, Jianhua Li, Weiqiang Chen, Huan Yang, Ping Wang, Kevin J Tracey, Haichao Wang
JournalJournal of leukocyte biology (J Leukoc Biol) Vol. 111 Issue 1 Pg. 261-267 (01 2022) ISSN: 1938-3673 [Electronic] England
PMID33759207 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Copyright© 2021 The Authors. Journal of Leukocyte Biology published by Wiley Periodicals LLC on behalf of Society for Leukocyte Biology.
Chemical References
  • Antibodies, Monoclonal
  • Recombinant Proteins
  • Spike Glycoprotein, Coronavirus
  • spike protein, SARS-CoV-2
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • ACE2 protein, human
  • Angiotensin-Converting Enzyme 2
Topics
  • Amino Acid Motifs
  • Angiotensin-Converting Enzyme 2 (metabolism)
  • Animals
  • Antibodies, Monoclonal (metabolism)
  • Granulocyte-Macrophage Colony-Stimulating Factor (metabolism)
  • Humans
  • Leukocytes, Mononuclear (metabolism)
  • Macrophages (metabolism)
  • Mice
  • Protein Binding
  • RAW 264.7 Cells
  • Recombinant Proteins (metabolism)
  • Spike Glycoprotein, Coronavirus (chemistry, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: